EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)

PHASE3CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

October 31, 2006

Conditions

HyperphosphatemiaKidney Failure

Interventions

DRUG

calcium acetate

667 mg gelcaps, 1-3 t.i.d. (titrated to serum phosphorus level)

DRUG

placebo

gelcap, 1-3 t.i.d. (titrated to serum phosphorus level)

Trial Locations (1)

University of Texas Health Sciences Center, San Antonio